Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Donatella Sangari"'
Publikováno v:
Drugs in Context, Vol 10, Pp 1-9 (2021)
Interstitial lung diseases (ILDs) are some of the first and most serious complications of connective tissue diseases (CTDs). However, the pathogenesis of CTD-related ILDs (CTD-ILDs) is still unclear and their treatment often depends on functional and
Externí odkaz:
https://doaj.org/article/7dbb2cbbbb104370b84a79389c0a10f3
Autor:
Gianluca Bagnato, Alessandra Bitto, Natasha Irrera, Gabriele Pizzino, Donatella Sangari, Maurizio Cinquegrani, William Neal Roberts, Marco Atteritano, Domenica Altavilla, Francesco Squadrito, Gianfilippo Bagnato, Antonino Saitta
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-1 (2022)
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13075-022-02973-w.
Externí odkaz:
https://doaj.org/article/feab4f513bec4f998b88795aa1d0b2d3
Autor:
Marco Atteritano, Stefania Sorbara, Gianluca Bagnato, Giovanni Miceli, Donatella Sangari, Salvatore Morgante, Elisa Visalli, Gianfilippo Bagnato
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e66991 (2013)
OBJECTIVE: The aim of our study was to elucidate the pathophysiology of systemic sclerosis-related osteoporosis and the prevalence of vertebral fragility fracture in postmenopausal women with systemic sclerosis (SSc). METHODOLOGY: Fifty-four postmeno
Externí odkaz:
https://doaj.org/article/b0003cdbe9a149d49212fc29c5d75388
Autor:
Antonio Giovanni Versace, Caterina Oriana Aragona, Daniela La Rosa, Marianna Chiappalone, Maria Concetta Tringali, Alberta De Gaetano, Charles Frederick Moore, Donatella Sangari, William Neal Roberts, Gianluca Bagnato
Publikováno v:
Rheumato; Volume 1; Issue 1; Pages: 22-30
Introduction/Objective: The efficacy of biologic therapy in the treatment of rheumatoid arthritis (RA) has been well-established but, in practice, a quarter of patients will either not respond to the first biologic agent or will suffer an adverse eve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78afbd5b77a1fe41365c8c70267d256f
https://doi.org/10.3390/rheumato1010005
https://doi.org/10.3390/rheumato1010005
Autor:
Laura La Corte, Elisabetta Gerratana, Donatella Sangari, Valeria Nucera, Fabiola Atzeni, Manuela Giallanza
Publikováno v:
Drugs in Context, Vol 10, Pp 1-9 (2021)
Drugs in Context
Drugs in Context
Interstitial lung diseases (ILDs) are some of the first and most serious complications of connective tissue diseases (CTDs). However, the pathogenesis of CTD-related ILDs (CTD-ILDs) is still unclear and their treatment often depends on functional and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::381eb5a589676f05ad1900b464dbc520
https://www.drugsincontext.com/efficacy-of-cyclophosphamide-in-treating-connective-tissue-disease-related-interstitial-lung-diseases
https://www.drugsincontext.com/efficacy-of-cyclophosphamide-in-treating-connective-tissue-disease-related-interstitial-lung-diseases
Autor:
Gianfranco Miceli, Donatella Sangari, Elisabetta Gerratana, Fabiola Atzeni, Ignazio Francesco Masala, Laura La Corte, Valeria Nucera, Manuela Giallanza
Publikováno v:
Expert Opinion on Biological Therapy
SARS-CoV-2 is a novel coronavirus that was first isolated from a group of patients hospitalized with pneumonia in China at the end of 2019, and, in February 2020, the syndrome it caused was named coronavirus disease 2019 (COVID-19) by the World Healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a77e5d6cb0b42a6271ce9b8ebb099afd
Autor:
Elisabetta Gerratana, Ignazio Francesco Masala, Mariateresa Cirillo, L. Boccassini, Valeria Nucera, Donatella Sangari, Fabiola Atzeni, Francesca Marino, Gianfranco Miceli
Publikováno v:
Expert opinion on drug safety. 19(6)
More than 15 years after its introduction, there is still no agreement as to whether anti-TNF treatment increases the risk of developing infections, cardiovascular or neurological diseases, or auto-antibodies. Anti-TNF drugs reduce inflammation and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d55dd859ff3a0ce041598b70a49e2c68
https://pubmed.ncbi.nlm.nih.gov/32401624
https://pubmed.ncbi.nlm.nih.gov/32401624
Autor:
Francesca Marino, Rossella Talotta, Ignazio Francesco Masala, Elisabetta Gerratana, Piercarlo Sarzi-Puttini, Valeria Nucera, Donatella Sangari, Fabiola Atzeni
Publikováno v:
Expert Review of Clinical Immunology. 14:945-956
A new class of oral synthetic drugs has been developed for the treatment of rheumatoid arthritis (RA) with the aim of blocking the Janus kinase/signal transducer and activator of transcription (JAK-STAT) system. Tofacitinib and baricitinib have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6476e393e3c2ef0cabf32af8df00b65
https://doi.org/10.1080/1744666x.2018.1504678
https://doi.org/10.1080/1744666x.2018.1504678
Autor:
Gianluca Bonitta, Piercarlo Sarzi-Puttini, Pietro Muto, Alessia Fiorenza, Elisabetta Gerratana, Fausto Salaffi, Francesca Marino, Donatella Sangari, Fabiola Atzeni
Publikováno v:
Psoriatic arthritis.
Background Evaluating psoriatic arthritis (PsA)-related enthesitis is diagnostically and therapeutically essential, but may be very complex because of the wide range of signs and symptoms that partly overlap or co-exist with the clinical features of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d03fcb831903bd9c6516e155e6958b94
https://doi.org/10.1136/annrheumdis-2019-eular.3764
https://doi.org/10.1136/annrheumdis-2019-eular.3764
Autor:
Donatella Sangari, Fabiola Atzeni, Gianfranco Miceli, Francesca Marino, Valeria Nucera, Elisabetta Gerratana, Ignazio Francesco Masala, Alessia Fiorenza
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::600296e3a83c361175dea0713246838e
http://hdl.handle.net/11570/3151561
http://hdl.handle.net/11570/3151561
